Last reviewed · How we verify
NCT06133920
Duration of Immobilization After Reverse Total Arthroplasty for Proximal Humerus Fractures
trial testing Early Range of Motion in Proximal Humeral Fracture in 40 participants. Currently enrolling.
1 February 2026
Quick facts
| Lead sponsor | The Cooper Health System |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 24 February 2021 |
| Primary completion | 1 February 2026 |
| Estimated completion | 1 February 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Early Range of Motion
- Immobilization
Conditions studied
- Proximal Humeral Fracture — all drugs for Proximal Humeral Fracture →
- Reverse Total Shoulder Arthroplasty — all drugs for Reverse Total Shoulder Arthroplasty →
Sponsor
The Cooper Health System — full company profile →
Who can join
60 and older, any sex, with Proximal Humeral Fracture or Reverse Total Shoulder Arthroplasty. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate compare postoperative range of motion in patients who are given a sling for comfort only and allowed to start early active range of motion compared to patients who are placed in a sling for 4 weeks with passive range of motion only. Once enrolled, the patients will be randomized through computer randomization then placed in paper packets into either the immobilization group or the early range of motion group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06133920
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Proximal Humeral Fracture
Currently open trials in the same condition.
- NCT06416618 — Surgical Versus Non-surgical Treatment of Displaced Proximal Humerus Fracture in Adults Aged 50 to 65 Years · NA · recruiting
- NCT05703958 — Exactech Proximal Humerus Fracture Plate System Post Market Clinical Follow-up · recruiting
- NCT06444828 — Comparing Outcomes of Non-surgical Versus Surgical Treatment of Shoulder Fractures With Different Shoulder Replacements · NA · active not recruiting
- NCT04523415 — Researches About Proximal Humerus Fractures · recruiting
- NCT03531463 — The Nordic DeltaCon Trial for Displaced Proximal Humeral Fractures in Elderly · NA · active not recruiting
Other The Cooper Health System trials
Trials by the same sponsor.
- NCT07296120 — RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients · Phase 4 · not yet recruiting
- NCT07042048 — Placing External Ventricular Drains Using Assistive Augmented Reality or Image-Based Localization · NA · not yet recruiting
- NCT06462781 — Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment Phase 1 · Phase 1 · completed
- NCT05974423 — Randomized Trial of Narcotic vs Non-Narcotic Pain Modulation After Labrum Repair · Phase 4 · unknown
- NCT06398366 — Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06133920 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Cooper Health System
- Last refreshed: 20 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06133920.